control is the most bothersome patient-reported side effect of prostate surgery. In addition to incontinence, many men experience some degree of erectile dysfunction following radical prostatectomy, depending on a number of factors including how potent the patient was prior to surgery, patient age, tumor stage, and how the neurovascular bundles were preserved during surgery. This side-effect is a frustrating and inconvenient experience. In many cases, the recovery of sexual function can take up to 24 months.
Additional Targeted Tissue Cooling
In addition to use in radical prostatectomies, targeted tissue cooling as developed for the UroCool catheter has a number of potential future clinical applications for tissue cooling in the pelvic region. These include other urological procedures such as radical cystectomy, a common procedure used to treat bladder cancer that has spread into the bladder wall. There are also a number of gynecological and colorectal cooling opportunities, including radical hysterectomy, myomectomy for removing fibroids from the uterus, and various types of transvaginal surgery.
About Cardium
Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.
Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac ar
'/>"/>
SOURCE Cardium Therapeutics Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal2.
Palomar and Q-MED AB Terminate International Distribution Agreement3.
Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar4.
PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference5.
ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement6.
Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group7.
Probiotic Delivery Technology Awarded Third International Patent8.
Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement9.
The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy10.
Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots11.
MINRAD International, Inc. Announces Reduction in Workforce